The xCELLigence RTCA eSight enables comprehensive insight into cell health, cell behavior, cell function and cell biology processes using live, simultaneous, and real time biosensor impedance-based and image-based measurements. The eSight system combines the label-free xCELLigence RTCA technology with live cell imaging in 3 colors (red, green, and blue). This combination allows for informative live cell analysis and increased insight into cell health.
Impedance: Simple workflow, label free, highly sensitive and robust. Very easy automated data output. Ideal for capturing rapid cellular changes.
Imaging: Ideal for suspension cells, single cell analysis, monitoring rare populations, 3D tumor spheroids, and other applications.
|Analyzer Application||Adhesion||Apoptosis||Cell Characterization|
|Cytotoxity||Immune Cell Killing||Proliferation|
|Receptor Signaling||Stem Cells||Virus Cytopathic Effects|
|Live Cell Imaging|
|Operating Environment Relative Humidity||5-98 %|
|Operating Environment Temperature||20-40 °C|
|Sampling Format||3 x 96-well plate||5 x 96 well plates|
The eSight offers a unique combination of the features of xCELLigence with live cell imaging. Even more information can be gathered from the live cell analysis when using impedance-based biosensors and image-based measurements together. Both quantitative and qualitative phenotypic information about cell health, behaviour, function and biology processes can be gathered through these combined technologies. The eSight images in 3 colours: red, green, and blue to provide powerful and informative images of cells.
• Cancer immunotherapy:
With the monitoring of cell killing
• Virology & Infectious diseases:
Monitor pathogens behaviour
• Cell signalling:
Capture changes in cell behaviour due to signalling
• Cytotoxicity Overview:
Monitor cell behaviour and attachment to the plate surface
• Cell Barrier Function:
Continuous monitoring of the cell barrier
• Cell Adhesion:
Studying cell adhesion and cell spreading
Please login to be able to see the application notes.